Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James White

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2020
Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial HypertensionRichard D Bell, R James White, Maria L Garcia-Hernandez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2024
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE studyRaymond L Benza, Gérald Simonneau, Hossein-Ardeschir Ghofrani, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical TrialR James White, Carlos Jerjes-Sanchez, Gisela Martina Bohns Meyer, et al.
Circulation|January 9, 2020
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)D Ian Paterson, George Wells, Fernanda Erthal, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Science Advances|January 13, 2018
The largest deep-ocean silicic volcanic eruption of the past centuryRebecca Carey, S Adam Soule, Michael Manga, et al.
Pilot and Feasibility Studies|November 4, 2025
Models of housing and support to reduce risks of COVID-19 infection and homelessness: the moving on pilot randomised controlled trialPeter Mackie, Elizabeth Randell, Calie Dyer, et al.
The Lancet. Respiratory Medicine|October 18, 2016
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION studyMarius M Hoeper, Vallerie V McLaughlin, Joan Albert Barberá, et al.
Advances in Therapy|December 6, 2023
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label ExtensionEkkehard Grünig, Franck Rahaghi, Jean Elwing, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2020
Tumor Necrosis Factor Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease-Associated Pulmonary Arterial HypertensionRichard D Bell, R James White, Maria L Garcia-Hernandez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2024
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE studyRaymond L Benza, Gérald Simonneau, Hossein-Ardeschir Ghofrani, et al.
JACC. Heart Failure|May 22, 2026
Refining the Definition for "Low Risk" in Pulmonary Arterial Hypertension: Time to Reduce Morbidity and MortalityCharles Fauvel, Priscilla Correa Jaque, Yongqi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical TrialR James White, Carlos Jerjes-Sanchez, Gisela Martina Bohns Meyer, et al.
Circulation|January 9, 2020
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)D Ian Paterson, George Wells, Fernanda Erthal, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Science Advances|January 13, 2018
The largest deep-ocean silicic volcanic eruption of the past centuryRebecca Carey, S Adam Soule, Michael Manga, et al.
Pilot and Feasibility Studies|November 4, 2025
Models of housing and support to reduce risks of COVID-19 infection and homelessness: the moving on pilot randomised controlled trialPeter Mackie, Elizabeth Randell, Calie Dyer, et al.
The Lancet. Respiratory Medicine|October 18, 2016
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION studyMarius M Hoeper, Vallerie V McLaughlin, Joan Albert Barberá, et al.
Advances in Therapy|December 6, 2023
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label ExtensionEkkehard Grünig, Franck Rahaghi, Jean Elwing, et al.
Pageof 29